A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2007
11/21/2007	EP1623711B1 External patch containing estrogen and/or progestogen
11/21/2007	EP1578750B1 Cationic porphyrin derivatives as antibacterial agents
11/21/2007	EP1482920B1 Compositions containing n-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
11/21/2007	EP1443918B1 Calcium l-threonate for treating bone facture
11/21/2007	EP1414492B1 Method for treating multiple myeloma
11/21/2007	EP1313464B1 Method for treatment of reactive arthritis or bursitis
11/21/2007	EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007	EP1263958B1 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
11/21/2007	EP0842196B1 Cell adhesion inhibitors
11/21/2007	CN101076539A Crystal and deforming shaped smilagenin
11/21/2007	CN101076352A Il-15 antigen array and its application
11/21/2007	CN101074210A Pharmaceutically active isoindoline derivatives
11/21/2007	CN101073662A Qianwu capsules for stretching tendon and analgesia
11/21/2007	CN101073651A Oral liquid for eliminating thrombus and spur
11/21/2007	CN101073644A Chinese-medicinal liquor for treating rheumatosis
11/21/2007	CN101073635A Paste
11/21/2007	CN101073633A Chinese-herb medicinal preparation for treating various rheumatalgia, neuralgia and hyperosteogeny
11/21/2007	CN101073630A Externally-applied cream for treating various diseases
11/21/2007	CN101073621A Medicinal composition for treating rheumatic pain
11/21/2007	CN101073608A Pill for treating hyperosteogeny
11/21/2007	CN101073571A Medicinal composition for treating cold wet numbness and its production
11/21/2007	CN101073559A Adamantine rattan slow release-controlled agent and its production
11/21/2007	CN101073542A Weight-losing cream
11/21/2007	CN100350051C Glucosamine and method of making glucosamine from microbial biomass
11/21/2007	CN100349887C Substituted 4-aryl-4H-pyrrolo[2,3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2007	CN100349611C Redfish calcitonin inhalation powder-atomizing agent and preparing method
11/21/2007	CN100349593C Bone-setting pain-stopping plaster
11/21/2007	CN100349577C Radix scutellariae total flavone extract and use of Radix scutellaride glucoside in preparing medicine for treating osteoporosis
11/20/2007	US7297818 Adamantane derivatives
11/20/2007	US7297681 For use in therapy of growth metabolic disorders
11/20/2007	US7297523 Human elongase genes and uses thereof
11/20/2007	CA2254144C Pharmaceutical compositions based on diclofenac
11/20/2007	CA2140382C Vitamin d compounds and method of preparing these compounds
11/15/2007	WO2007130712A1 Substituted dipiperidine as ccr2 antagonists for the treatment of inflammatory diseases
11/15/2007	WO2007130075A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
11/15/2007	WO2007129743A1 Anti-inflammatory composition
11/15/2007	WO2007129701A1 Method of producing dry yeast containing s-adenosyl-l-methionine and composition for oral intake
11/15/2007	WO2007129473A1 Bicyclic aryl derivative
11/15/2007	WO2007129019A1 Sulfonamide compounds useful as edg receptor modulators
11/15/2007	WO2007128896A2 Protease inhibitor compound, notably papain, cathepsin k and cathepsin b, and a procedure for the purification of protease inhibitor molecules
11/15/2007	WO2007128465A1 Xanthone derivative for the treatment of muscular disorders
11/15/2007	WO2007059874A3 Compositions for the treatment of osteoarthritis and to nourish the synovial fluid
11/15/2007	WO2006089537A8 Method for production of a preparation of a solid dmso-containing silicone oil emulsion for the binding of reactive oxygen compounds in human and animal bodies
11/15/2007	WO2006039704A3 Pharmaceutical composition and method for treating a joint capsule arthropathy
11/15/2007	US20070265327 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal
11/15/2007	US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007	US20070265318 Estrogen Receptor Modulators
11/15/2007	US20070265308 5-[5-(2-chloro-4-fluorophenyl)-2-piperidin-4-yl-1,3-thiazol-4-yl]-1-(2,6-dichlorophenyl)pyridin-2(1H)-one; p38 MAP kinase inhibitory activity; inflammatory, respiratory , circulatory and central nervous diseases; rheumatoid arthritis
11/15/2007	US20070265296 Nuclear receptor binding agents
11/15/2007	US20070265286 Quinazoline derivatives as VEGF inhibitors
11/15/2007	US20070265283 Xanthine Oxidase Inhibitor
11/15/2007	US20070265264 Thia-tetraazaacenaphthylene kinase inhibitors
11/15/2007	US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007	US20070265212 Drug Transport and Delivery System
11/15/2007	US20070265208 Association of calpain inhibitors and reactive oxygen species trapping agents
11/15/2007	US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007	US20070265196 Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein
11/15/2007	US20070265188 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
11/15/2007	US20070265187 Oral Formulations Comprising Bone Morphogenetic Proteins For Treating Metabolic Bone Diseases
11/15/2007	US20070264370 Composition and methods for the treatment of joint pain using Angelica gigas Nakai extract and powder as combined with Glucosamine Sulfate, or Chondroitin Sulfate and HCL, or MSM, or aspirin, or Celedrin, and as combinations thereof in powder, pill, capsule, spray, liquid, and gelcap form
11/15/2007	US20070264245 Compositions and minimally invasive methods for treating incomplete tissue repair
11/15/2007	US20070264240 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation
11/15/2007	US20070264232 Cell populations which co-express CD49c and CD90
11/15/2007	US20070264230 Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands
11/15/2007	CA2649627A1 Methods and compositions for remediation of disc herniation by modifying structure
11/15/2007	CA2618646A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
11/14/2007	EP1854793A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY
11/14/2007	EP1854787A1 Novel cyclic compound having quinolylalkylthio group
11/14/2007	EP1854484A1 Pain remedy containing rock inhibitor
11/14/2007	EP1854470A1 Method of treating inflammation disorders using extracts of passion fruit
11/14/2007	EP1854462A1 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
11/14/2007	EP1854460A1 External plaster containing flurbiprofen
11/14/2007	EP1853570A2 Hsp90-inhibiting triazole derivatives
11/14/2007	EP1853348A1 A herbal mixture extract of rehmanniae radix preparata and acanthopanacis cortex and a composition comprising the same for prevention and treatment of osteoporosis
11/14/2007	EP1853279A1 Amide derivatives of hyaluronic acid in osteoarthrosis
11/14/2007	EP1853274A2 2-methylene-19-nor- (20s-24s) - 1alpha, 25-d hydroxyvitamine-d2
11/14/2007	EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007	EP1853255A1 Methods for treating arthritis using triheterocyclic compounds
11/14/2007	EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007	EP1469835B1 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
11/14/2007	EP1423012B1 Medical use of stem cells expressing vegfr-1
11/14/2007	EP1286691B1 Methods for treatment of diseases associated with acute inflammation under non-ischemic conditions
11/14/2007	EP1235592B1 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament
11/14/2007	EP1212086B1 Immunological tolerance-induction agent
11/14/2007	EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007	CN101072554A Therapeutic treatment of accelerated bone resorption
11/14/2007	CN101072509A Treatment and prevention of inflammatory disorders
11/14/2007	CN101070323A Porphyrin derivative, its preparing method and use of same as small-molecular anti-oxidation agent
11/14/2007	CN101069716A Chinese medicine composition for treating osteoporous and preparing method
11/14/2007	CN101069699A Bone-tonifying pills for promoting bone growth
11/14/2007	CN101069683A Meclofenoxate hydrochloride medicine use
11/14/2007	CN101069676A Method for preparing brufen soft capsule
11/14/2007	CN101069568A Method for preparing nutrient instant gruel of millet flour and sugar
11/14/2007	CN100348600C Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors
11/14/2007	CN100348584C 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
11/14/2007	CN100348244C Method for making traditional Chinese medicine for treating hyperosteogeny
11/14/2007	CN100348239C Chinese traditional medicine for curing soft tissue pains and process for preparing the same
11/14/2007	CN100348219C Medical pillow and its manufacturing method
11/14/2007	CN100348208C Method for preparing Chinese medicinal preparation of whiteback thundergodvine by water decoction alcohol precipitation
11/14/2007	CN100348207C Use of sea-buckthorn fruit oil and/or fruit slag oil in preparing medicine for treating osteoporosis

1 ... 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 ... 820